The easy book of cancer pharmacology /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Cidon, Esther Una (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Biomedical, [2016]
Colección:Cancer etiology, diagnosis, and treatments.
Temas:
Cancer > Chemotherapy.
Clinical pharmacology.
Pharmacology.
Antineoplastic Agents > pharmacology
Pharmacology, Clinical
Pharmacology
Cancer > Chimiothérapie.
Pharmacologie clinique.
Pharmacologie.
pharmacology.
HEALTH & FITNESS / Diseases / General
MEDICAL / Clinical Medicine
MEDICAL / Diseases
MEDICAL / Evidence-Based Medicine
MEDICAL / Internal Medicine
Antineoplastic agents.
Handbooks and manuals.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • THE EASY BOOK OF CANCER PHARMACOLOGY; THE EASY BOOK OF CANCER PHARMACOLOGY; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; PREFACE; Chapter 1: ABIRATERONE: ABIRATERONE ACETATE: CB7630: ZYTIGA®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; Mechanism of Action; Pharmacokinetics [2]; Mechanism of Resistance; Indications [2]; Dosages; Methods of Preparation/Administration; Special Information and Cautions [2]; Contraindications; Elderly Patients; Pediatric Patients; Renal Impairment; Hepatic Impairment; Immunisations; Warnings [2]
  • Mineralocorticoid ExcessAdrenocortical Insufficiency; Hepatotoxicity; Food Effect; Toxicities [2]; Dose Modifications [2]; Interactions [2]; CONCLUSION; REFERENCES; Chapter 2: ALBUMIN-BOUND (NAB) PACLITAXEL, ABRAXANE® ; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; MECHANISM OF ACTION; Pharmacokinetics; INDICATIONS; Metastatic Breast Cancer; Metastatic Pancreatic Adenocarcinoma; Dosages; METHODS OF PREPARATION/ADMINISTRATION; SPECIAL INFORMATION AND CAUTIONS; Contraindications; Elderly; Pediatric; Renal; Hepatic; Immunisations; Pregnancy; Breast-Feeding
  • TOXICITIES [9, 10]Dose Modifications; INTERACTIONS; CONCLUSION; REFERENCES; Chapter 3: AFLIBERCEPT. ZALTRAP®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; MECHANISM OF ACTION; MECHANISM OF RESISTANCE; PHARMACOKINETICS [6]; INDICATIONS; DOSAGES; METHODS OF PREPARATION/ADMINISTRATION [6]; SPECIAL INFORMATION AND CAUTIONS [6]; Contraindications; Elderly Patients; Pediatric Patients; Renal Impairment; Hepatic Impairment; WARNINGS [6]; Hemorrhage; Gastrointestinal Perforation; Compromised Wound Healing; Fistula Formation; Hypertension; Arterial Thromboembolic Events
  • ProteinuriaNeutropenic Complications; Diarrhea and Dehydration; Pregnancy and Nursing; Immunisations; TOXICITIES; DOSE MODIFICATIONS; INTERACTIONS; CONCLUSION; REFERENCES; Chapter 4: AXITINIB. INLYTA®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; Mechanism of Action; Pharmacokinetics [2, 3]; Mechanism of Resistance [3]; Indications; Dosage; Methods of Preparation/Administration [1]; Special Information and Cautions [1]; Contraindications; Elderly; Pediatric; Renal Impairment; Hepatic Impairment; Breast-Feeding; Pregnancy; Immunisations; Warnings [1]; Hypertension
  • Thromboembolic EventsHemorrhagic Events; Toxicities [1]; Dose Modifications [1]; Hepatic Impairment; Concomitant Strong CYP3A4/5 Inhibitors; Concomitant Strong CYP3A4/5 Inducers; Interactions [1]; CYP3A4/5 Inhibitors; CYP1A2 and CYP2C19 Inhibitors; CYP3A4/5 Inducers; CONCLUSION; REFERENCES; Chapter 5: BEVACIZUMAB. AVASTIN®; ABSTRACT; INTRODUCTION; DRUG CLASSIFICATION; MECHANISM OF ACTION; PHARMACOKINETICS; MECHANISM OF RESISTANCE; INDICATIONS [10]; DOSAGES [10] ; METHODS OF ADMINISTRATION/PREPARATION [10]; SPECIAL INFORMATION AND CAUTIONS [10]; Contraindications; Elderly Patients

Ejemplares similares